216 related articles for article (PubMed ID: 35717644)
1. Kinetics of Maternally Derived Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies in Infants in Relation to the Timing of Antenatal Vaccination.
Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Porat S; Wolf DG
Clin Infect Dis; 2023 Feb; 76(3):e274-e279. PubMed ID: 35717644
[TBL] [Abstract][Full Text] [Related]
2. Timing of SARS-CoV-2 vaccination during the third trimester of pregnancy and transplacental antibody transfer: a prospective cohort study.
Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
Clin Microbiol Infect; 2022 Mar; 28(3):419-425. PubMed ID: 34740773
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Gestational Age at BNT162b2 mRNA Vaccination on Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Levels.
Rottenstreich A; Zarbiv G; Oiknine-Djian E; Vorontsov O; Zigron R; Kleinstern G; Wolf DG; Porat S
Clin Infect Dis; 2022 Aug; 75(1):e603-e610. PubMed ID: 35171998
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Anti-SARS-CoV-2-Specific Antibody Signatures in Maternal and Infant Blood after COVID-19 Infection versus COVID-19 Vaccination during Pregnancy.
Sabharwal V; Taglauer E; Demos R; Snyder-Cappione J; Shaik-Dasthagirisaheb YB; Parker-Kelleher S; Hunnewell J; Boateng J; Clarke K; Yuen R; Barnett ED; Wachman EM; Yarrington CD
Am J Perinatol; 2024 May; 41(S 01):e2970-e2977. PubMed ID: 37774748
[TBL] [Abstract][Full Text] [Related]
5. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
Scaggs Huang F
J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
[TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity.
Conti MG; Terreri S; Terrin G; Natale F; Pietrasanta C; Salvatori G; Brunelli R; Midulla F; Papaevangelou V; Carsetti R; Angelidou A
Clin Infect Dis; 2022 Aug; 75(Suppl 1):S37-S45. PubMed ID: 35535796
[TBL] [Abstract][Full Text] [Related]
7. Maternal and Cord Anti-SARS-CoV-2-Spike IgG following COVID-19 Vaccination versus Infection during Pregnancy: A Prospective Study, Israel October 2021-March 2022.
Abu Shqara R; Frank Wolf M; Mikhail Mustafa S; Sgayer I; Assulyn T; Abu Zraki A; Askhar Majadla N; Rechnizter H; Shehadeh M; Fleisher Sheffer V; Bordeynik-Cohen M; Yakir O; Lowenstein L; Sela E; Edelstein M; Dror AA
Am J Perinatol; 2024 May; 41(S 01):e1935-e1943. PubMed ID: 37164317
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Anti-SARS-CoV-2-specific IgG Levels in Breast Milk after Vaccination or COVID-19 Infection.
Temocin F; Çaycı YT; Seren C; Kuruoglu T; Atilla A; Birinci A; Tanyel E
Am J Perinatol; 2024 May; 41(S 01):e3085-e3090. PubMed ID: 37846474
[TBL] [Abstract][Full Text] [Related]
9. IgG antibody levels against the SARS-CoV-2 spike protein in mother-child dyads after COVID-19 vaccination.
Muñoz-Gómez MJ; Martin-Vicente M; Vigil-Vazquez S; Carrasco I; Lobo AH; Mas V; Vázquez M; Manzanares A; Cano O; Zamora C; Alonso R; Sepulveda-Crespo D; Tarancon-Diez L; Muñoz-Fernández MÁ; Muñoz-Chapuli M; Resino S; Navarro ML; Martinez I
Infection; 2024 Jun; 52(3):813-824. PubMed ID: 37898587
[TBL] [Abstract][Full Text] [Related]
10. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Immunity to SARS-CoV-2 During Pregnancy Provides More Durable Infant Antibody Responses Compared to Natural Infection Alone.
LaCourse SM; Wetzler EA; Aurelio MC; Escudero JN; Selke SS; Greninger AL; Goecker EA; Barnes SR; Arnould IS; Pérez-Osorio AC; Richardson BA; Kachikis A; Englund JA; Drake AL
J Infect Dis; 2024 Jun; 229(6):1728-1739. PubMed ID: 38128542
[TBL] [Abstract][Full Text] [Related]
12. Impact of maternal SARS-CoV-2 booster vaccination on blood and breastmilk antibodies.
Rick AM; Lentscher A; Xu L; Wilkins MS; Nasser A; Tuttle DJ; Megli C; Marques ETA; McElroy AK; Williams JV; Martin JM
PLoS One; 2023; 18(6):e0287103. PubMed ID: 37310982
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Adverse Reactions, Antibody Patterns, and 12-month Outcomes in the Mother-Infant Dyad After COVID-19 mRNA Vaccination in Pregnancy.
Cassidy AG; Li L; Golan Y; Gay C; Lin CY; Jigmeddagva U; Chidboy MA; Ilala M; Buarpung S; Gonzalez VJ; Basilio E; Duck M; Murtha AP; Wu AHB; Lynch KL; Asiodu IV; Prahl MK; Gaw SL
JAMA Netw Open; 2023 Jul; 6(7):e2323405. PubMed ID: 37450302
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL
Front Immunol; 2021; 12():777103. PubMed ID: 34804068
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection.
Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Briker SM; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Hensley SE; Puopolo KM
JAMA Netw Open; 2022 Nov; 5(11):e2240993. PubMed ID: 36350652
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women.
Yeo KT; Chia WN; Tan CW; Ong C; Yeo JG; Zhang J; Poh SL; Lim AJM; Sim KHZ; Sutamam N; Chua CJH; Albani S; Wang LF; Chua MC
Front Immunol; 2021; 12():783975. PubMed ID: 35087517
[TBL] [Abstract][Full Text] [Related]
17. Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G Levels After the Pfizer-BioNTech Booster Dose for Coronavirus Disease 2019 (COVID-19) Vaccination During the Second Trimester of Pregnancy.
Kugelman N; Nahshon C; Shaked-Mishan P; Kleifeld S; Cohen N; Sher ML; Zahran H; Barsha H; Assaf W; Shalabna E; Stein N; Lavie O; Kedar R; Riskin-Mashiah S
Obstet Gynecol; 2022 Aug; 140(2):187-193. PubMed ID: 35852268
[TBL] [Abstract][Full Text] [Related]
18. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
[TBL] [Abstract][Full Text] [Related]
19. Efficient transplacental transfer of SARS-CoV-2 antibodies between naturally exposed mothers and infants in Accra, Ghana.
Partey FD; Obiri D; Bonney EY; Pobee ANA; Damptey IK; Ennuson K; Akwetea-Foli J; Nuokpem FY; Courtin D; Kusi KA; Mensah BA
Sci Rep; 2024 May; 14(1):10772. PubMed ID: 38730052
[TBL] [Abstract][Full Text] [Related]
20. Antibody response, neutralizing potency, and transplacental antibody transfer following SARS-CoV-2 infection versus mRNA-1273, BNT162b2 COVID-19 vaccination in pregnancy.
Dude CM; Joseph NT; Forrest AD; Verkerke HP; Cheedarla N; Govindaraj S; Irby LS; Easley KA; Smith AK; Stowell SR; Neish A; Amara RR; Jamieson DJ; Dunlop AL; Badell ML; Velu V
Int J Gynaecol Obstet; 2023 Jul; 162(1):154-162. PubMed ID: 36598270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]